Concepedia

Pengfei Zhou

PZ

Statistics

Publications

38

Citations

2.1K

H-Index

25

Active since

2002

Affiliations

Wuhan YZY Biopharma (China)(Current)

Huazhong University of Science and Technology

Tongji Hospital

Chongqing Medical University

Stomatological Hospital of Chongqing Medical University

Pengfei Zhou is an author at Wuhan YZY Biopharma (China) specializing in oncology, medicine, and life sciences.

ORCID

Publications per year

2002–2025

38

Publications

38

The construction, expression, and enhanced anti-tumor activity of YM101: a bispecific antibody simultaneously targeting TGF-β and PD-L1

Ming Yi, Jing Zhang, Anping Li et al. · Journal of Hematology & Oncology · 2021 · 253 citations · Full text

, , +17

Combine and conquer: manganese synergizing anti-TGF-β/PD-L1 bispecific antibody YM101 to overcome immunotherapy resistance in non-inflamed cancers

Ming Yi, Mengke Niu, Jing Zhang et al. · Journal of Hematology & Oncology · 2021 · 178 citations · Full text

, , +17

Combination of oral STING agonist MSA-2 and anti-TGF-β/PD-L1 bispecific antibody YM101: a novel immune cocktail therapy for non-inflamed tumors

Ming Yi, Mengke Niu, Yuze Wu et al. · Journal of Hematology & Oncology · 2022 · 178 citations · Full text

, , +17

Anti-TGF-β/PD-L1 bispecific antibody promotes T cell infiltration and exhibits enhanced antitumor activity in triple-negative breast cancer

Ming Yi, Yuze Wu, Mengke Niu et al. · Journal for ImmunoTherapy of Cancer · 2022 · 161 citations · Full text

, , +17

Circulating tumor microemboli (CTM) and vimentin+ circulating tumor cells (CTCs) detected by a size-based platform predict worse prognosis in advanced colorectal cancer patients during chemotherapy

Dejun Zhang, Lei Zhao, Pengfei Zhou et al. · Cancer Cell International · 2017 · 107 citations · Full text

, , +15

1–5 of 38